 |
|
Calcium Blockers in Smooth-Muscle DisordersCurrent Status
Marc L. Schwartz, MD;
Heschi H. Rotmensch, MD;
Peter H. Vlasses, PharmD;
Roger K. Ferguson, MD
Arch Intern Med. 1984;144(7):1425-1429.
Abstract
• Calcium-entry blockers have proven efficacy in a variety of cardiovascular disorders. The effects of these agents on ionic calcium fluxes and, thus, on smooth-muscle contraction suggest that several noncardiac conditions involving smooth-muscle dysfunction may be managed with calcium antagonists. Beneficial therapeutic results have been reported in various forms of hypertension and Raynaud's phenomenon. The results of preliminary studies in treating pulmonary hypertension, cerebral arterial spasm, migraine headache, esophageal motility disorders, and myometrial hypercontractile states are encouraging. Carefully designed, large-scale and long-term clinical trials are needed to establish the therapeutic value of calcium-entry blockers in these disorders.
(Arch Intern Med 1984;144:1425-1429)
Author Affiliations
From the Divisions of Cardiology (Dr Schwartz) and Clinical Pharmacology (Drs Rotmensch, Vlasses, and Ferguson), Departments of Medicine and Pharmacology, Jefferson Medical College, Thomas Jefferson University, Philadelphia.
Footnotes
Accepted for publication Feb 7, 1984.
Reprint requests to the Division of Clinical Pharmacology (M-502), Thomas Jefferson University Hospital, 11th and Walnut Streets, Philadelphia, PA 19107 (Dr Rotmensch).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Hypertensive Emergencies and Urgencies
Ferguson and Vlasses
JAMA 1986;255:1607-1613.
ABSTRACT
Hypertensive Crisis Associated With Nifedipine Withdrawal
Bursztyn et al.
Arch Intern Med 1986;146:397-397.
ABSTRACT
|
